Droxidopa
Droxidopa is an orally active, blood-brain barrier permeable precursor to norepinephrine. It is utilized in research for neurogenic orthostatic hypotension (nOH) and as an alternative ADHD treatment model, with studies demonstrating its ability to elevate blood pressure and improve orthostatic tolerance in vivo.
Product Specifications
CAS Number
23651-95-8
Product Name Alternative
Inhibit, Inhibitor, orally active, neurogenic orthostatic hypotension, L-DOPS, AdrenergicReceptor, ADHD, Adrenergic Receptor, blood pressure, Beta Receptor, Droxidopa, DOPS, SM5688, SM-5688, SM 5688
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
97.27% (May vary between batches)
Solubility
H2O:1.25 mM; DMSO:2.14 mg/mL (10.04 mM)
Smiles
N[C@@H] ([C@H] (O) c1ccc (O) c (O) c1) C (O) =O
Molecular Formula
C9H11NO5
Molecular Weight
213.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
DZ00135-1-carrier-free 200 µL/Vial
Anti-Giardia lamblia eIF4E Antibody, Carrier-free
Sign In for Pricing
View Details 
G2021-56A-Biotin 200 µL
GATA6, phosphorylated (Tyr271) (GATA Binding Factor 6, GATA Binding Protein 6, Transcription Factor GATA-6) (Biotin) discontinued
Sign In for Pricing
View Details